Recipients of meningococcal vaccines have a small chance of experiencing a severe allergic reaction, and they may experience fainting spells, fever or mild side effects, such as pain or redness, as stated by the Centers for Disease Control and Prevention. There are also reports of several cases of Guillain-Barre syndrome.Continue Reading
More than 25 cases of Guillain-Barre syndrome, or GBS, a serious neurological condition, have occurred in individuals within six weeks of receiving the MCV4 vaccine known as Menactra, according to the CDC. The majority of affected recipients were between the ages of 11 and 19. This incidence comes from the statistics of more than 15 million doses of the vaccine distributed until 2008. Anyone with a history of Guillain-Barré syndrome should not take the MCV4 vaccine.
Adolescents have the highest risk of experiencing faintness, jerking movements or seizure-like movements following a meningococcal vaccine, as stated by the CDC. To minimize risk of fall and injury, recipients should lie down for approximately 15 minutes after receiving the shot. Up to half of vaccine recipients experience mild side effects, such as pain or redness at the site of the shot. Anyone who experiences concerning symptoms following a meningococcal vaccination should call a doctor immediately.Learn more about Medications & Vitamins